Aida, Virginia <br/><br/>
Acute administration of perampanel, an AMPA receptor antagonist, reduces cognitive impairments after traumatic brain injury in rats.  [electronic resource] 

 -  Experimental neurology  05 2020 
 - 113222 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1090-2430 
<br/><br/><label>Standard No.: </label>10.1016/j.expneurol.2020.113222  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Brain Injuries, Traumatic--complications<br/>Cognition--drug effects<br/>Cognitive Dysfunction--drug therapy<br/>Disease Models, Animal<br/>Excitatory Amino Acid Antagonists--pharmacology<br/>Hippocampus--drug effects<br/>Male<br/>Maze Learning--drug effects<br/>Neuroprotective Agents--pharmacology<br/>Nitriles<br/>Pyridones--pharmacology<br/>Rats<br/>Rats, Sprague-Dawley<br/>Receptors, AMPA--antagonists & inhibitors<br/>Spatial Memory--drug effects<br/>Treatment Outcome<br/>bcl-2-Associated X Protein--metabolism<br/>bcl-X Protein--metabolism